Biophys are delighted to have presented the Outstanding Achievement Award to BiVictriX Therapeutics at the sixteenth annual MediWales Innovation Awards on 2nd December 2021.

The prestigious awards ceremony was held at the Mercure Holland House Hotel in Cardiff and is designed to recognise the achievements of the life science network and representative body for Wales, particularly after a very challenging time for this community. It’s more important than ever that these achievements be celebrated.

The full award categories and winners were as follows:

Industry Awards;

● Innovation - Creo Medical

● Start Up - IQ Endoscopes

● Export - CellPath

● Partnership with the NHS - Alpha Laboratories

● Outstanding Achievement - BiVictrix Therapeutics

● Covid Response - British Rototherm Group NHS Awards;

● NHS Wales Working with Industry - Cwm Taf Morgannwg Health Board

● Digital Impact - Betsi Cadwaladr University Health Board Pharmacy

● Scaling Up Innovation and Transformation - All Wales Medical Genomics Service and Velindre Cancer Centre

● Health and Social Care Research Partnership Award with Industry - Hwyel Dda University Health

● NHS Judges Award - Cardiff and Vale University Health Board, Eye Care

Biophys presented the Outstanding Achievement Award for the third time since the awards began and are proud to deliver the award to worthy winner BiVictriX Therapeutics.

Founded in 2017, and drawing upon frontline clinical experience, BiVictriX is a rapidly emerging biotechnology company, applying a novel approach to develop safer, more effective cancer therapies. BivictriX have developed therapeutics, which are uniquely selective for particular cancer types, to enable higher dosing and more aggressive cancer eradication without causing harmful side-effects.

Dr Michael Graz of Biophys, who has over 25 years of commercial, teaching and research experience in life sciences said of the winner: “BiVictriX’s work in tackling Acute Myeloid Leukaemia personally resonates with me as I have family currently suffering from AML, and I wish them well in bringing their concept to the market as soon as possible.”

Biophys are proud members of MediWales. Their values are aligned; servicing, supporting and giving a voice to healthcare partners in life sciences across the world.

MediWales has over 180 members from medical technology, NHS health boards, university research departments and pharmaceutical industries. They create collaboration through a programme of well-attended events focuses on life science, market access, finance, international trade and special interest groups. MediWales support the creation of business opportunities and partnerships for its

members whilst improving access to vital clinical expertise and engaging with the government to align support with sector needs. To find out more about this year’s winners, click here. To find out more about Biophys and their support of life sciences, click here.